Optometrists in Arkansas City, KS Accepting Medicare
9 Optometrists found. Showing 1 - 9
 Dr. Kristina Lynn Post, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2508 Edgemont Dr, Suite 6, Arkansas City, KS 67005 Phone: 620-442-2577 Fax: 620-442-2578 |
 Dr. Miles M Abbey, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 520 N Summit St, Arkansas City, KS 67005 Phone: 620-442-1111 Fax: 620-442-2628 |
Madeline Smith, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2508 Edgemont Dr Ste 6, Arkansas City, KS 67005 Phone: 620-442-2577 |
Heidi Nicole Ensley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2508 Edgemont Dr, Ste 6, Arkansas City, KS 67005 Phone: 620-442-2577 Fax: 620-442-2578 |
Dr. Stewart L Abbey, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 520 N Summit St, Arkansas City, KS 67005 Phone: 620-442-1111 Fax: 620-442-2628 |
Dr. Jayna D Munson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 520 N Summit St, Arkansas City, KS 67005 Phone: 918-442-1111 |
 Abbey Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 520 N Summit St, Arkansas City, KS 67005 Phone: 620-442-1111 |
Tran Majher And Shaw O.d. P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2508 Edgemont Dr Ste 6, Arkansas City, KS 67005 Phone: 620-442-2577 Fax: 620-442-2578 |
Rod D Stoy Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2508 Edgemont Dr, Suite #6, Arkansas City, KS 67005 Phone: 620-442-2577 Fax: 620-442-2578 |
News Archive
CRF Health to present on ePRO data collection methods at DIA EuroMeeting
CRF Health, a leading global provider of ePRO solutions for the Life Sciences Industry will be joined by industry colleagues at the DIA EuroMeeting for a session on the topic ePRO data collection methods.
Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress
QLT Inc. today announced that final results from the Novartis-sponsored Phase IIIb DENALI study were presented on June 8, 2010 during the World Ophthalmology Congress in Berlin. DENALI was a 24-month randomized, double-masked, multicenter trial in patients with subfoveal choroidal neovascularization secondary to wet age-related macular degeneration (all lesion types).
Study suggests new application for endovascular grafts
Tumors have the potential to grow locally and invade neighboring organs. Some chest tumors may invade one of the great vessels of the body, the aorta. Surgical removal of these tumors is very challenging and necessitates the support of a heart-lung machine.
Advanced assay offers better sensitivity for detecting a prion disease affecting elk
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a family of rare progressive, neurodegenerative illnesses that affect both humans and animals. TSE surveillance is important for public health and food safety because TSEs have the potential of crossing from animals to humans, as seen with the spread of mad cow disease, or bovine spongiform encephalopathy (BSE). A study in The Journal of Molecular Diagnostics describes an advanced assay that offers better sensitivity than currently available tests for detecting a prion disease affecting elk.
› Verified 7 days ago
Optometrists
Chiropractors
Physical Therapists
Speech-Language Pathologists